Brain cancer vaccine prepared from brain tumor proves effective
Brain cancer vaccine proves effective — With help of patient groups, phase 2 clinical trial paves way for testing therapy that combines cancer vaccine with the drug Avastin – A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme-which kills thousands of Americans every year.